AI Scribe for Pain Management: Separate the Note From the Check

A pain-management scribe can draft the visit narrative. It cannot turn an unperformed PDMP review, an unseen image, or a planned procedure into completed evidence. The pilot should test that boundary on purpose. Keep source-system checks, prescribing authority, and the final signed decision with the people and tools that own them.

Thursday’s refill visit has two clocks

One clock follows the conversation: pain since the last visit, function, response, adverse effects, and what the patient reports taking. The other follows actions outside the conversation: source records reviewed, examinations performed, decisions made, and orders actually authorized.

An ambient draft can help with the first clock. It must not fake the second.

Statement in the draftEvidence ownerAcceptance test
Patient reports a change in functionPatient conversationAttribution remains explicit
Clinician reviewed PDMP dataAuthorized clinician and PDMPReview occurred and is recorded according to local policy
Procedure was performedProcedure record and clinicianDate, site, laterality, and completion agree
Medication was prescribedPrescriber and prescribing systemDraft discussion is not presented as transmission
ICD-10 candidateClinician or authorized coding reviewerSuggestion is accepted, changed, or rejected before use

This is the core buying test. The note can be concise or long. Source confusion is the failure.

PDMP review is not a sentence-generation task

CDC describes a prescription drug monitoring program as an electronic database that tracks controlled-substance prescriptions. Its clinical guidance points clinicians to Recommendation 9 of the 2022 opioid guideline and says PDMP information should be reviewed at defined prescribing moments to assess risk (CDC PDMP guidance). The full guideline also addresses PDMP review and the benefits and risks of toxicology testing (CDC 2022 guideline).

This article is not prescribing advice. The operational point is narrower: a draft that says “PDMP reviewed” needs evidence from the authorized workflow. Hearing those words in a room is not the same thing as accessing the source database. A clinic’s medical, compliance, and legal owners should define when the check occurs and how it is documented.

Patient Square does not access a PDMP, perform toxicology review, transmit prescriptions, or provide EPCS. It can draft what was discussed. The clinician verifies the record and completes required work in the approved systems.

Use a missing-fact drill

Build three synthetic encounters for the pilot. In one, the patient reports a medication but the dose is not stated. In another, a prior procedure is discussed but today’s laterality is never spoken. In the third, the clinician says a source check will happen after the visit.

Now read the drafts cold. Any filled-in dose, inferred laterality, or completed check is a stop signal. Mark it, correct it, and record how the vendor responds. A useful system should make uncertainty visible to the reviewer instead of smoothing it into confident prose.

Run the same cases twice: once with the clinician narrating relevant findings clearly, and once with normal conversational shorthand. The difference tells you how much workflow change the product demands. The federal Health IT Playbook recommends common demonstration scenarios and structured testing against practice needs (ASTP/ONC Health IT Playbook).

Define the product boundary before price

Patient Square is an AI clinical platform. Its AI Medical Scribe drafts a structured SOAP note, ICD-10 suggestions, and a prescription draft for clinician review. Practice Copilot can sit alongside the clinic’s current EHR or use the bundled Patient Square EHR, named AI Copilot EHR on the pricing page, from the Copilot tier. US annual pricing is $79 per physician per month for Assist and $119 for Copilot (Patient Square pricing).

The boundaries matter more here than the price. Patient Square does not claim PDMP access, EPCS, pharmacy transmission, procedure-device integration, imaging review, or a coding engine. A pain clinic that needs those functions should keep or buy systems that provide them.

We think the right trial question is not “Did the AI write a complete note?” Ask, “Can a reviewer tell which facts came from the room and which controls happened somewhere else?” The ICD-10 suggestions explainer covers the coding boundary, while the prescription-draft safety guide covers the difference between a draft and transmission. Book a demo after your missing-fact cases are written.

FAQ

Common questions

Can Patient Square prescribe controlled substances?

No. Patient Square creates a prescription draft for clinician review. It does not transmit a prescription, connect to a pharmacy, perform EPCS, or replace the prescriber's required checks. Keep prescribing, identity proofing, PDMP access, and final authorization in the approved clinical systems.

What should a pain clinic test in an AI scribe pilot?

Use one new consultation, one medication follow-up, and one procedure follow-up. Check source attribution, functional history, clinician-stated findings, and the boundary between discussed and completed actions. Include a deliberately missing fact and confirm that the draft does not fill the gap on its own.

Does an AI-drafted note determine the E/M level?

No. A longer note does not decide the service level. The clinician and billing team must apply current rules to the care actually delivered and the signed record. Patient Square offers ICD-10 suggestions only; it does not claim CPT, E/M, HCC, or autonomous coding.

Is a pain-management AI scribe a replacement for a specialty EHR?

Not by default. An ambient scribe handles the spoken documentation layer. A specialty EHR may also manage prescribing, PDMP access, procedure records, imaging, devices, and billing workflows. Buy against the missing job, and keep any system that owns a required clinical control.

Sources

  1. CDC: 2022 Clinical Practice Guideline for Prescribing Opioids for Pain (reviewed September 2026).
  2. CDC: Prescription Drug Monitoring Programs clinical guidance (reviewed September 2026).
  3. ASTP/ONC Health IT Playbook: EHR selection and testing resources (reviewed September 2026).
  4. Patient Square US pricing and current module scope (reviewed September 2026).